First PREMIER Bank Has $160,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

First PREMIER Bank raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 7.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 274 shares of the healthcare conglomerate’s stock after acquiring an additional 18 shares during the quarter. First PREMIER Bank’s holdings in UnitedHealth Group were worth $160,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the stock. Delta Financial Group Inc. grew its position in shares of UnitedHealth Group by 1.0% in the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after acquiring an additional 17 shares during the period. Signature Resources Capital Management LLC increased its position in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 18 shares during the last quarter. Saxony Capital Management LLC boosted its stake in shares of UnitedHealth Group by 3.5% during the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after acquiring an additional 18 shares during the period. GoalVest Advisory LLC raised its stake in UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after acquiring an additional 18 shares during the period. Finally, Fiduciary Group LLC boosted its position in UnitedHealth Group by 0.5% during the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after purchasing an additional 18 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded up $3.96 during midday trading on Wednesday, reaching $585.54. The company’s stock had a trading volume of 33,752 shares, compared to its average volume of 3,929,426. The stock has a market cap of $540.70 billion, a PE ratio of 35.55, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The business has a 50-day moving average price of $582.68 and a 200-day moving average price of $529.13.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the prior year, the firm earned $6.14 EPS. The firm’s revenue was up 6.4% compared to the same quarter last year. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on UNH shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Tuesday, October 1st. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price target for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. HSBC lifted their target price on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. UBS Group raised their price target on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Finally, Barclays increased their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.